Screen Shot 2019-09-25 at 2.41.25 PM - Spero

About
Pipeline
Antibiotic Resistance
Blog
Investors & Media
Partners
Careers
Contact

Screen Shot 2019-09-25 at 2.41.25 PM

About
Management Team
Board of Directors
Contact

Pipeline
Tebipenem HBr: Oral Gram-Negative Program
SPR720: Nontuberculous Mycobacterium
SPR206: Direct Acting IV Potentiator
Key Publications and Presentations

Antibiotic Resistance

Partners

Investors & Media
Overview
News Releases
Spero in the News
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
IR Resources

Careers

©2022 Spero Therapeutics All Rights Reserved

Privacy Policy
Terms of Use